Kristine Peterson

Kristine Peterson

Directeur/Bestuurslid bij IMMUNOCORE HOLDINGS PLC

Vermogen: - $ op 30-04-2024

64 jaar
Health Technology
Commercial Services
Consumer Services

Oorsprong van het eerstegraads netwerk van Kristine Peterson

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 146
Public Company Pharmaceuticals: Major 47
Subsidiary Biotechnology 42
University of Illinois At Urbana–Champaign
36
College/University Other Consumer Services 36
Public Company Biotechnology 23
Public Company Pharmaceuticals: Major 21
Public Company Pharmaceuticals: Major 18
Subsidiary Medical Specialties 16
Public Company Pharmaceuticals: Major 16
Public Company Pharmaceuticals: Major 12
7
Subsidiary Pharmaceuticals: Major 7
Subsidiary Medical Specialties 6
5
Extinct Pharmaceuticals: Major 5
4
Subsidiary Miscellaneous Commercial Services 4
3
Subsidiary Pharmaceuticals: Major 3
Greater Philadelphia Life Sciences Congress
1
Subsidiary 1

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Kristine Peterson via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Miscellaneous Commercial Services

Daniel Junius

Joseph Scodari

John Johnson

James Healy

Mark Enyedy

Jennifer Taubert

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Medical Specialties

Jan van Heek

William Duke

Mark Enyedy

David B. Johnston

Mark Goldberg

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Christine Poon

Aaron Berg

Richard Wallace

Rosemary Crane

Douglas Pagán

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Lesley Russell

Zheng Bin Yao

Bahija Jallal

Robin LaChapelle

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

President

Human Resources Officer

ELI LILLY AND COMPANY Pharmaceuticals: Major

John Johnson

Joseph Zakrzewski

Timothy Franson

Travis Coy

President

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Pharmaceuticals: Major

David Mazzo

Aaron Berg

John Landis

Stacey Seltzer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

SARISSA CAPITAL ACQUISITION CORP. Financial Conglomerates

Odysseas Kostas

Keith Horn

Mark Dipaolo

Patrice Bonfiglio

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Director of Finance/CFO

VIELA BIO, INC. Biotechnology

Zheng Bin Yao

Bahija Jallal

Christian Nolet

Jim Kastenmayer

Chief Executive Officer

Director/Board Member

Director/Board Member

General Counsel

Indiana University College/University

Joseph Zakrzewski

Robin LaChapelle

Timothy Franson

Siddharth Kaul

Masters Business Admin

Undergraduate Degree

Corporate Officer/Principal

Masters Business Admin

Miscellaneous Commercial Services

Yujiro Hata

Stacey Seltzer

Morten Aleksandr Engel

Mary Margaret Huizinga

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ASTRAZENECA PLC Pharmaceuticals: Major

Zheng Bin Yao

Bahija Jallal

Robin LaChapelle

Jim Kastenmayer

Corporate Officer/Principal

Corporate Officer/Principal

Human Resources Officer

General Counsel

University of Oxford College/University

John Bell

Yujiro Hata

Peter Ratcliffe

Corporate Officer/Principal

Undergraduate Degree

Corporate Officer/Principal

University of Michigan College/University

Michael Johns

David B. Johnston

Christophe Soulier

Doctorate Degree

Masters Business Admin

Masters Business Admin

Massachusetts Institute of Technology College/University

Carl Gordon

Odysseas Kostas

Morten Aleksandr Engel

Doctorate Degree

Undergraduate Degree

Doctorate Degree

ACCELERON PHARMA INC. Biotechnology

Carl Gordon

Joseph Zakrzewski

Douglas Pagán

Director/Board Member

Director/Board Member

Director of Finance/CFO

University of Pennsylvania College/University

John R. Barr

Ron I. Honig

William Hait

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Georgetown University Law Center College/University

Keith Horn

Mark Dipaolo

Jim Kastenmayer

Graduate Degree

Graduate Degree

Graduate Degree

BIOGEN INC. Pharmaceuticals: Major

Robert Perez

Daniel Char

Douglas Pagán

Corporate Officer/Principal

Corporate Officer/Principal

Director of Finance/CFO

The Wharton School of the University of Pennsylvania College/University

Yujiro Hata

Stacey Seltzer

Luke Düster

Masters Business Admin

Masters Business Admin

Masters Business Admin

NOVARTIS AG Pharmaceuticals: Major

Mary Margaret Huizinga

Jason Marks

Siddharth Kaul

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Göran Albert Ando

John Landis

Morten Aleksandr Engel

Chairman

Director/Board Member

Director/Board Member

Harvard College College/University

Carl Gordon

Mark Goldberg

Paul Cohen

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Joseph T. Kennedy

John Thero

Karim Mikhail

Corporate Secretary

Chief Executive Officer

Chief Executive Officer

Kellogg School of Management College/University

Daniel Junius

John R. Barr

Evan Norton

Graduate Degree

Masters Business Admin

Masters Business Admin

Harvard Law School College/University

Mark Enyedy

Louis Sterling

Daniel Char

Graduate Degree

Graduate Degree

Graduate Degree

Pharmaceuticals: Major

John Johnson

Timothy Franson

Jennifer Taubert

Director/Board Member

Corporate Officer/Principal

Director/Board Member

C.R. BARD Medical Specialties

George Elston

Carla Sivak

Corporate Officer/Principal

Corporate Officer/Principal

The Rockefeller University College/University

Roy Herbst

Paul Cohen

Doctorate Degree

Corporate Officer/Principal

Weill Cornell Medical College College/University

Roy Herbst

Paul Cohen

Doctorate Degree

Doctorate Degree

Tufts University College/University

Daniel Char

Leonard S. Ross

Undergraduate Degree

Undergraduate Degree

OCERA THERAPEUTICS INC Pharmaceuticals: Major

John Johnson

Lars Ekman

Chairman

Director/Board Member

Miscellaneous Commercial Services

Roy Herbst

William Hait

Director/Board Member

Treasurer

Miscellaneous Commercial Services

Evan Norton

Christian Nolet

Corporate Officer/Principal

Corporate Officer/Principal

GSK PLC Pharmaceuticals: Major

Eliot Forster

Manus Rogan

Corporate Officer/Principal

Corporate Officer/Principal

College/University

William Perez

Elizabeth Forminard

Director/Board Member

Undergraduate Degree

Pharmaceuticals: Major

Joseph Scodari

Karen McGrath

Director/Board Member

Human Resources Officer

Hospital/Nursing Management

Roy Herbst

William Hait

Corporate Officer/Principal

Director/Board Member

Pharmaceuticals: Major

Joseph Scodari

John Johnson

Chairman

Private Equity Investor

Investment Managers

James Healy

Lars Ekman

Private Equity Investor

Private Equity Investor

AUDENTES THERAPEUTICS, INC. Biotechnology

James Healy

Mark Goldberg

Director/Board Member

Director/Board Member

Boston University College/University

Christine Poon

Ron I. Honig

Masters Business Admin

Corporate Officer/Principal

ENZON PHARMACEUTICALS, INC. Pharmaceuticals: Major

Göran Albert Ando

Odysseas Kostas

Director/Board Member

Director/Board Member

Yale University College/University

Stacey Seltzer

Roy Herbst

Graduate Degree

Graduate Degree

CYTEIR THERAPEUTICS, INC. Biotechnology

John Thero

Joseph Zakrzewski

Director/Board Member

Chairman

Statistieken

Internationaal

Verenigde Staten 43
Verenigd Koninkrijk 5
Ierland 2
Zwitserland 2
Denemarken 2

Sectoraal

Health Technology 28
Consumer Services 16
Commercial Services 5
Finance 4
Health Services 2

Operationeel

Director/Board Member 623
Corporate Officer/Principal 277
Independent Dir/Board Member 236
Chairman 118
Director of Finance/CFO 87
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU